161 Global Pharmaceuticals & Biotech Stocks - High Insider Buying - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
NDVA Indiva	CA$0.07	16.7%	0%	CA$13.7m	n/a	PB36.9x	S11.6%	n/a
GTG Genetic Technologies	AU$0.12	-32.4%	-61.7%	AU$15.2m	AU$1.00	PS1.5x	E130.5%	n/a
SOFTX SoftOx Solutions	kr0.20	-8.2%	-97.1%	kr101.7m	n/a	PS14.6x	n/a	n/a
HASH Simply Solventless Concentrates	CA$0.23	4.5%	n/a	CA$12.6m	n/a	PE25x	n/a	n/a
CHRO Chromocell Therapeutics	US$1.57	-21.1%	n/a	US$9.2m	n/a	PE-1.3x	n/a	n/a
BRTX BioRestorative Therapies	US$1.27	-8.6%	-68.5%	US$9.1m	US$10.50	PS59x	E50.2%	n/a
TOL Toleranzia	kr0.50	-5.7%	-48.0%	kr98.5m	n/a	PS1.9x	n/a	n/a
BETR.F BetterLife Pharma	US$0.072	-6.6%	32.2%	US$8.6m	n/a	PE-4.4x	n/a	n/a
CANB CanadaBis Capital	CA$0.08	6.7%	-63.6%	CA$11.8m	n/a	PE3.4x	n/a	n/a
XRTX XORTX Therapeutics	CA$3.95	-8.1%	-48.4%	CA$11.4m	n/a	PB1.8x	E120.0%	n/a
AROC AroCell	kr0.36	-2.7%	-42.8%	kr84.1m	kr1.30	PS2x	E28.7%	n/a
RVV Revive Therapeutics	CA$0.025	0%	-70.6%	CA$10.5m	n/a	PB1.1x	n/a	n/a
RNO Rhinomed	AU$0.04	-7.0%	-55.6%	AU$11.5m	n/a	PS1.4x	n/a	n/a
AZTR Azitra	US$0.22	12.5%	n/a	US$6.7m	US$3.50	PS9.4x	E3.8%	n/a
PKTX ProtoKinetix	US$0.019	33.8%	-29.6%	US$6.5m	n/a	PB15.3x	n/a	n/a
COOL Core One Labs	CA$0.18	-7.7%	-60.0%	CA$8.5m	n/a	PS18.5x	n/a	n/a
EMMA Emmaus Life Sciences	US$0.10	-12.1%	-66.7%	US$5.7m	n/a	PE-1.3x	n/a	n/a
RAMM RAMM Pharma	CA$0.06	0%	-14.3%	CA$7.2m	n/a	PS1.5x	n/a	n/a
SILO Silo Pharma	US$1.88	-4.1%	-17.2%	US$5.1m	US$10.00	PS74.1x	E-43.2%	n/a
LIPO Lipella Pharmaceuticals	US$0.71	-4.8%	-62.1%	US$5.0m	US$2.00	PS11.2x	E29.4%	n/a
PALI Palisade Bio	US$6.35	-3.8%	-73.7%	US$5.0m	US$33.75	PS21.6x	E-14.0%	n/a
OCTP Oxford Cannabinoid Technologies Holdings	UK£0.0035	-1.4%	-72.0%	UK£3.8m	n/a	PB2x	E15.1%	n/a
RKV Rakovina Therapeutics	CA$0.09	-5.3%	-40.0%	CA$6.3m	n/a	PB1.5x	n/a	n/a
PCSA Processa Pharmaceuticals	US$1.62	-2.4%	-84.7%	US$4.6m	US$4.00	PB0.9x	E36.9%	n/a

Global Pharmaceuticals & Biotech High Insider Buying